Biochemistry, Genetics and Molecular Biology
Lamb
100%
Carnitine Palmitoyltransferase I
92%
Alpha Oxidation
76%
Beta Oxidation
37%
Outer Mitochondrial Membrane
34%
Erythropoietin
30%
Heme Oxygenase
30%
C-Terminus
30%
Progeny
30%
Intron
30%
Blood Pressure
30%
Endothelial Progenitor Cell
30%
Metabolic Pathway
30%
Hypovitaminosis D
30%
Pannexin
30%
Ketone Bodies
30%
Green Fluorescent Protein
16%
Exon
12%
Enzyme
11%
Isoform
10%
Glucose Oxidation
7%
Solution and Solubility
7%
Isotope-Ratio Mass Spectrometry
7%
Alternative Splicing
6%
Amino Acids
6%
P1 Phage
6%
Messenger RNA
6%
Molecular Cloning
6%
Fluorescence in Situ Hybridization
6%
Binding Site
6%
Polyadenylation
6%
Epigenetics
5%
Pyruvate Dehydrogenase
5%
Methylation
5%
DNA Methylation
5%
Sprague Dawley Rat
5%
Diastolic Blood Pressure
5%
Promoter Region
5%
Systolic Blood Pressure
5%
Vitamin D
5%
Vitamin Deficiency
5%
Hypovitaminosis
5%
Medicine and Dentistry
Neonatal Infant
58%
Lactic Acid
46%
Fatty Acid
40%
Heart Muscle Metabolism
35%
Atrial Fibrillation
30%
Aortopulmonary Shunt
30%
Early Growth Response Factor 1
30%
Calcineurin
30%
Ketone Bodies
30%
Gluconeogenesis
30%
Long Chain Fatty Acid
30%
Growth Differentiation Factor 15
30%
Pulmonary Hypertension
30%
Right Ventricle
30%
Heart Failure
30%
Lung Artery Banding
20%
Childbirth
19%
Heart Muscle Oxygen Consumption
18%
Persistent Truncus Arteriosus
14%
Myocardium
13%
Hypoglycemia
13%
Exercise
10%
Synapsin I
10%
Left Ventricle
10%
Myosin Heavy Chain Alpha
10%
Glycogenolysis
8%
Glucose Metabolism
8%
Pyruvic Acid
8%
Aortocaval Fistula
7%
Infusion
6%
Lung Blood Flow
5%
Monocrotaline
5%
Cardiac Magnetic Resonance Imaging
5%
Heart Right Ventricle Failure
5%
Right Ventricular Hypertrophy
5%
Heart Right Ventricle Function
5%
Keyphrases
Carnitine Palmitoyltransferase 1A (CPT1A)
30%
Pulmonary Hypertension
30%
Long-chain Fatty Acid Oxidation
30%
Lamb
30%
Myocardial Metabolism
30%
Lactate Oxidation
30%
Neointimal
30%
Early Growth Response Protein 1 (EGR1)
30%
Usage Analysis
30%
Patients with Heart Failure
30%
Atrial Fibrillation
30%
Growth Differentiation factor-15 (GDF-15)
30%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
30%
Pulmonary Arterial Hypertension
19%
Pressure Load
15%
Myocardial Oxygen Consumption
14%
FA Oxidation
13%
Newborn Lambs
11%
Fetal Lambs
11%
Glucose Production
10%
Right Ventricular Output
10%
Pulmonary Blood Flow
9%
Mast Cell Stabilization
8%
Pulmonary Vascular Hemodynamics
8%
Neointimal Lesion
8%
Labeled Substrates
7%
Maternal Vitamin D Deficiency
7%
Endothelial-dependent Relaxation
7%
Hemichannel
7%
Lactate
7%
Moderate Exercise
6%
Cori Cycle
6%
Monocrotaline
5%
Degree of Hypertrophy
5%
Right Ventricular Volume
5%
Shunt Surgery
5%
Wheel Exercise
5%
Pathological Hypertrophy
5%
Right Ventricular Dilatation
5%
